![Nicolas Poirier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Poirier
No más puestos en curso
Fortuna: 6 M $ al 31/05/2026
Perfil
Nicolas Poirier worked as a Project Manager at Effimune SA. From 2016 to 2026, Dr. Poirier worked at OSE Immunotherapeutics SA, serving as Chief Scientific Officer from 2025 to 2026.
Dr. Poirier completed undergraduate studies at Centre d'Etudes Supérieures de Techniques Industrielles and graduate degrees at the University of Nantes and Louis Pasteur University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/09/2025 | 1.131.603 ( 4,99 % ) | 6 M $ | 31/05/2026 |
Antiguos cargos conocidos de Nicolas Poirier.
| Empresas | Cargo | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director Ejecutivo | 02/10/2025 |
Effimune SA
 Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Corporate Officer/Principal | - |
Formación de Nicolas Poirier.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
16
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Nantes
 University of Nantes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
Centre d'Etudes Supérieures de Techniques Industrielles
 Centre d'Etudes Supérieures de Techniques Industrielles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Louis Pasteur University
 Louis Pasteur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Nicolas Poirier
